Advertisement

Commentary to: Fertility potential in 5α-reductase type 2 deficient males

Published:October 14, 2022DOI:https://doi.org/10.1016/j.jpurol.2022.09.027
      Markouli et al. report the results of a systematic review of the literature where they identified 9 individuals with a detected mutation in the 5α-reductase type 2 enzyme gene that subsequently were able to conceive in their adult life [
      • Markouli M.
      • Michala L.
      Fertility potential in 5α-reductase type 2 deficient males.
      ]. This manuscript highlights the importance of early genotyping to confirm diagnosis. Diagnostic workup of patients with differences in sexual development is guided based on phenotype assessment and the tendency is to genotype (gene panel, exome, genome and more recently long-read sequencing) cases with what the clinician interprets as “severe/classic phenotype” or those with possible syndromic features [
      • Byers H.M.
      • Fossum M.
      • Wu H.Y.
      How geneticists think about differences/disorders of sexual development (DSD): a conversation.
      ]. Milder phenotype anomalies are generally not studied and rarely end up undergoing genetic sequencing. Variable expressivity and incomplete penetrance generates low genotype/phenotype correlation. Subtle phenotype nuances may not be evaluated in depth and accurate genetic diagnosis can be missed. Clinical impact of a lack or delayed diagnosis affects patient's and families at multiple levels. Recent reports have shown rising positive detection of mutations for milder phenotypes [
      • Ea V.
      • Bergougnoux A.
      • Philibert P.
      • Servant-Fauconnet N.
      • Faure A.
      • Breaud J.
      • et al.
      How far should we explore hypospadias? Next-generation sequencing applied to a large cohort of hypospadiac patients [formula presented].
      ]. Growing understanding of variants of uncertain significance may improve genetic detection in this group of patients. Genotyping milder phenotypes (isolated distal hypospadias) and ideally all cases with suspicion for a difference in sexual development, regardless of severity of the phenotype, will offer the ability to use the genotype as a predictive variable to guide management such as preoperative testosterone for specific reconstructive cases as well as a predictor for surgical outcomes beyond the current indications to guide diagnosis, counseling oncological risk, future fertility potential and future generation recurrence.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Pediatric Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Markouli M.
        • Michala L.
        Fertility potential in 5α-reductase type 2 deficient males.
        J Pediatr Urol [Internet]. 2022 Sep 9; (Available from:) (S1477-5131(22)00365-5. Epub ahead of print. PMID: 36153242)https://doi.org/10.1016/j.jpurol.2022.09.002
        • Byers H.M.
        • Fossum M.
        • Wu H.Y.
        How geneticists think about differences/disorders of sexual development (DSD): a conversation.
        J Pediatr Urol. 2020; 16: 760-767
        • Ea V.
        • Bergougnoux A.
        • Philibert P.
        • Servant-Fauconnet N.
        • Faure A.
        • Breaud J.
        • et al.
        How far should we explore hypospadias? Next-generation sequencing applied to a large cohort of hypospadiac patients [formula presented].
        Eur Urol. 2021 Apr 1; 79: 507-515

      Linked Article